This website uses „cookies“ for improving its effectiveness. Detailed information for "cookies" use is presented in Cookie policy. By using this website you agree to using „cookies“.

Find more
close icon

Search

  • Home
  • >
  • Therapeutic areas

Therapeutic areas


Therapeutic areas & diseases

The medicinal products and nutraceutical products of INBIOTECH are applicable in treatment of multiple therapeutic areas. Most of our products are intended for treatment of socially significant diseases, such as hypertension and heart failure, stomach and duaodenal ulcers, traumas, diseases of the respiratory system, etc.. Other products from our portfolio are intended for prevention and treatment of diseases, which are not socially signficant, but still are reason for deterioration of quality of life of large number of people. 



Socially significant diseases

Socially significant diseases are diseases of modern lifestyle. In the countries around the world nowadays these diseases are caused by abrupt changes in lifestyle, as well as by risk factors, such as stress, smoking, sedentary way of life, and intake of food, which is not healthy, among large groups of people. People who suffer from these diseases, as well as their families, are economically and psychologically burdened. Socially significant diseases often lead to deteriorated optimal execution of daily activities of these people, as well as disability. 



Our mission

We from INBIOTECH strive to provide highly-effective, high-quality, safe and affordable medicinal products and nutraceutical products to patients in Bulgaria, as well as in other countries in Europe, Asia, Africa and the Americas. We aim to contribute to reducing the number of patients, who suffer from these socially significant diseases. 

In close cooperation with the regulatory bodies in countries from these continents, as well as with medical doctors and pharmacists, our team accomplishes our mission -  our medicinal products and nutraceutical products to reach as much as possible patients in need of them, as well as to support their return to normal healthy and vital life. 



See more

Here you can learn more about the diseases, which our medicinal products and nutraceutical products cure and affect in the therapeutic areas, in which we are active.
Cardiology

Cardiology

Choose therapeutic area

Socially significant diseases

Socially significant diseases can be defined as diseases of contemporary lifestyle. These diseases are among the main reasons for morbidity and mortality among population of countries around the globe. Large and abrupt changes in lifestyle, as well as diverse risk factors (smoking, sedentary way of life, stress, intake of unhealthy food) sharply change the rate of socially significant diseases and in quite a few cases increase martality among large groups of people. 

Socially significant diseases economically and psychologically burden people and their families. These diseases often lead to disability, deteriorating optimal functioning in performance of daily activities. Socially significant diseases define the profile and structure of morbidity and mortality in a specific region in the world. 

Main socially significant diseases of the cardiovascular system

Some of the main socially significant diseases are the diseases of the cardiovascular system: ischemic heart disease, arterial hypertension and cerebrovascular disease.

Main risk factors for development of cardiovascular diseases

Hypertension is unlocking factor for cardiovascular diseases for all ages and genders. Affected glucose tolerance or diabetes are classified as additional atherogenic factors. Family predisposition also, intake of nicotine (smoking), sedentary lifestyle, as well as food rich in lipids are considered additional risk factors.

Prevention of cardiovascular diseases

Primary and secondary prevention includes groups of strategies for health promotion, related to reduction of specific risk factors - reduction of nicotine intake (smoking), obesity control, more adequate healthy eating habits, increase of physical activity. 

These strategies require institutional cooperation, education of the population, adequate information system for monitoring morbidity and prevalence of risk factors, as well as competent medical society.  

These activities should be population-based and they should be oriented to the individual. Population-based programmes that function with the aim to change lifestyle and habits become common way in help of public health. Some of the programmes for prevention of cardiovascular diaseses are:

* CINDI (Countrywide Integrated Noncommunicable Disease Intervention) programme for prevention. This is programme is developed by the WHO Regional Office for Europe (WHO/Europe) for prevention of chronic noncommunicable diseases (CNCDs). The programme was started in 1982. It is targeted towards society as a whole - children and adolescents, elderly people, as well as population in disadvantaged socioeconomic position. Bulgaria participates in the programme with several regions (Dobrich, Yambol, Vidin, Stara Zagora, Ruse, Gabrovo, Lovech and Veliko Tarnovo).

* MONICA (monitoring trends and determinants in cardiovascular disease) programme. This is epidemic prospective cohort study, which aims to clarify the reasons for differences in mortality due to ischemic heart disease (IHD) and serebrovascular disease (insult) in different countries and regions. 

Products from therapeutic area Cardiology

View more

Ivabradine

56 film-coated tablets

Indicated for treatment of chronic stable angina pectoris & chronic heart failure.

View more
View more

Enalapril maleate

20 tablets
50 tablets
60 tablets

Indicated for treatment of essential hypertension & all stages of heart failure.

View more
View more

Enalapril maleate

20 tablets

Indicated for treatment of essential hypertension & all stages of heart failure.

View more
View more

Enalapril maleate

20 tablets
60 tablets

Indicated for treatment of essential hypertension & all stages of heart failure.

View more
View more

Telmisartan / Hydrochlorothiazide

28 tablets

Indicated for treatment of essential hypertension.

View more
View more

Telmisartan / Hydrochlorothiazide

28 tablets

Indicated for treatment of essential hypertension.

View more
View more

Valsartan / Hydrochlorothiazide

28 film-coated tablets

Indicated for treatment of essential hypertension.

View more
View more

Highly esterified pure apple pectin with no added sugar

35 g powder for peroral solution

Indicated for adults & children above 15 years of age

Acts beneficially on functions of the cardiovascular system and others.

View more
View more

Pure deoiled soya lecithine

50 g granules

Indicated for adults & children above 15 yrears of age

Contributes to maintenance of the lipid balance in the organism.

View more
View more

L-ascorbic acid

40 tablets

Indicated for adults

Benefits functions of the immune system & assists overall resistance of the organism.

View more
View more

DL-Alpha-tocopheryl acetate

60 soft-gelatin capsules

Indicated for adults

Strongly contributes to natural defence of cells against oxidative stress and others.

View more
View more

L-ascorbic acid

30 ml drops

Indicated for babies from 3 months of age & for children up to 5 years of age

Favour normal function of childhood immune system & recovery processes.

View more

News from therapeutic area Cardiology

National Conference of General Medicine in Plovdiv, Bulgaria
04 September, 2018

National Conference of General Medicine in Plovdiv, Bulgaria

Read more
INBIOTECH participated in The XVI National Congress of Cardiology in Albena Resort

INBIOTECH participated in The XVI National Congress of Cardiology in Albena Resort

Read more